SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-13-052712
Filing Date
2013-10-04
Accepted
2013-10-04 20:48:54
Documents
1
Period of Report
2013-10-03

Document Format Files

Seq Description Document Type Size
1 FORM 4 rrd392344.html 4  
1 FORM 4 rrd392344.xml 4 3145
  Complete submission text file 0001181431-13-052712.txt   4461
Mailing Address 1301 2ND AVE. SUITE 3200 SEATTLE WA 98101
Business Address 1301 2ND AVE. SUITE 3200 SEATTLE WA 98101 206-219-7815
DENDREON CORP (Issuer) CIK: 0001107332 (see all company filings)

IRS No.: 223203193 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3005 FIRST AVENUE SEATTLE WA 98121
Business Address
Frohlich Mark W (Reporting) CIK: 0001420482 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35546 | Film No.: 131137796